Do I need to take other medicines after using Ohtuvayre (Ensifentrine)-Ensifentrine?

Using Ohtuvayre (Ensifentrine)-Ensefentine treatment in combination with other drugs usually depends on the patient's specific condition, the severity of the disease, and the doctor's clinical judgment. Ensefentin, as a new type of dual phosphodiesterase inhibitor , is mainly used to improve lung function and relieve respiratory symptoms in patients with chronic obstructive pulmonary disease (COPD). But in some cases, Ohtuvayre alone may not fully meet a patient's treatment needs.

For some COPD patients with complex symptoms it is often necessary to use other types of drugs in combination. For example, for airway inflammation and bronchospasm, doctors may recommend concurrent use of inhaled corticosteroids (ICS) or long-acting beta2-adrenoceptor agonists (LABA). This combined medication strategy can help effectively control the inflammatory response, while expanding the bronchi and improving the patient's respiratory status.

If patients experience acute exacerbation after taking Ohtuvayre, they may need to use short-acting β2-adrenoceptor agonists (SABA) to quickly relieve symptoms. This fast-acting drug can provide rapid relief during acute attacks, improve patients' dyspnea, and ensure timely disease control.

However, use caution when using Ohtuvayre as its compatibility with other medications has not been determined. According to the current instructions, Ohtuvayre should not be physically mixed with other drugs or added to solutions containing other drugs. This means that during nebulization treatment, exefentine cannot be co-nebulized with other drugs to avoid potential adverse reactions or reduced efficacy. Therefore, patients must follow their doctor's instructions when using Ohtuvayre to ensure the safety and effectiveness of the drug.

Reference materials:https://www.webmd.com/drugs/2/drug-189003/ensifentrine-inhalation/details